| Ytd | -10.28% | |
| 1y | 3.41% |
| Open | 11.06 | Prev Close | 11.23 | Low | 10.87 | High | 11.97 | Mkt Cap | 484.47M |
| Vol | 2.16M | Avg Vol | 557.83K | EPS | -0.88 | P/E | N/A | Forward P/E | -36.21 |
| Beta | 0.67 | Short Ratio | 2.88 | Inst. Own | 81.31% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 01-06 | 50-d Avg | 15.38 | 200-d Avg | 12.49 | 1yr Est | 13.00 |
AngioDynamics beats first-quarter earnings estimates as revenues rise 6.9% on strong Med Tech growth
AngioDynamics Inc. (NASDAQ:ANGO) stock plunged more than 21% Thursday despite reporting better-than-
ANGO stock drops 21% as AngioDynamics reports Q1 results, names Eric Honroth as new CEO, and reaffir
U.S. stocks fell Thursday as Nasdaq slid 150+ points; energy rallied, healthcare dropped. PepsiCo be
AngioDynamics, Inc. (ANGO) Q1 2027 Earnings Call Transcript
AngioDynamics beat on both top and bottom lines this morning. The company still lost $0.04 per share
AngioDynamics NASDAQ: ANGO reported fiscal 2027 first-quarter revenue growth of 6.9% to $80.9 millio
AngioDynamics (NASDAQ:ANGO) reported first-quarter financial results on Thursday. The transcript fro
AngioDynamics (ANGO) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Es
AngioDynamics (NASDAQ: ANGO - Get Free Report) updated its FY 2027 earnings guidance on Thursday. Th
Companies Reporting Before The Bell • Tilray Brands (NASDAQ:TLRY) is likely to report quarterly loss
Mr. Honroth will succeed Jim Clemmer, who will depart the Board on November 2, 2026, and will remain
AngioDynamics (NASDAQ:ANGO) affirms FY2027 Adj EPS guidance from $(0.29)-$(0.24) to $(0.29)-$(0.24)
AngioDynamics (NASDAQ:ANGO) reported quarterly losses of $(0.04) per share which beat the analyst co
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medi
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medi
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focu
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focu
Canada Pension Plan Investment Board purchased a new position in shares of AngioDynamics, Inc. (NASD
Bank of America Corp DE grew its holdings in shares of AngioDynamics, Inc. (NASDAQ: ANGO) by 262.7%
AngioDynamics (ANGO) reported earnings 30 days ago. What's next for the stock?
Gainers ENvue Medical (NASDAQ:FEED) shares rose 49.1% to $0.61 during Wednesday's after-market
AngioDynamics NASDAQ: ANGO expects its MedTech business to become the majority of company revenue in
AngioDynamics' Med Tech growth and reimbursement gains strengthen its outlook, but tariffs, rising c
AngioDynamics' fiscal 2027 outlook hinges on Med Tech growth offsetting flat device sales as tariffs
AngioDynamics' 33.5% three-month rally rests on Med Tech growth, but valuation, tariffs and negative
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medi
HC Wainwright & Co. analyst Yi Chen maintains AngioDynamics (NASDAQ:ANGO) with a Buy and rais
Canaccord Genuity analyst John Young maintains AngioDynamics (NASDAQ:ANGO) with a Buy and raises
AngioDynamics (NASDAQ:ANGO) released fourth-quarter financial results and hosted an earnings call on
Companies Reporting Before The Bell • Grupo Aeroportuario del (NYSE:PAC) is likely to report quarter
AngioDynamics (NASDAQ:ANGO) is looking for FY2027 Adj EPS of $(0.29)-$(0.24) vs $(0.16) analyst esti
AngioDynamics (NASDAQ:ANGO) reported quarterly losses of $(0.07) per share which beat the analyst co
AngioDynamics, Inc. (NASDAQ:ANGO), a medical technology company focused on restoring healthy blood f
U.S. stock futures surged on Wed. as Nasdaq futures rose over 7%, driven by AI. Marvell's stock
Pivotal U.S. Data Show Sustained Oncologic Control and Safety Profile at 24 monthsResults Presented
Canaccord Genuity analyst John Young maintains AngioDynamics (NASDAQ:ANGO) with a Buy and lowers
AngioDynamics (NASDAQ:ANGO) raises FY2026 Adj EPS guidance from $(0.33)-$(0.23) to $(0.30)-$(0.23) v
AngioDynamics (NASDAQ:ANGO) reported quarterly losses of $(0.07) per share which beat the analyst co
Stocks end higher, Fear & Greed Index eases, Trump suggests quick military withdrawal from Iran,
U.S. stock futures trading lower, Acuity and Visionary Holdings report strong earnings, Lindsay Cor
U.S. stock futures were fluctuating on Thursday following Wednesday's record advances. Futures o